Stocks making the biggest moves premarket: Tesla, Occidental Petroleum, Exxon Mobil and more

Business

In this article

Check out the companies making headlines before the bell:

Tesla (TSLA) – Tesla delivered 254,695 vehicles during the second quarter, down 17.9% from the first quarter and below what analysts had predicted. China’s Covid-19 shutdowns were a key factor in holding back production. Tesla fell 1% in premarket trading.

Occidental Petroleum (OXY) – Occidental gained 1.3% in the premarket following news that Berkshire Hathaway (BRKb) once again added to its stake in the energy producer. Berkshire bought 9.9 million more shares, boosting its stake to 17.4%.

Exxon Mobil (XOM) – Exxon rose 1.3% in premarket trading following its late Friday announcement that second-quarter earnings could be as much as $18 billion. Exxon’s results are getting a boost from rising oil and natural gas prices and higher refining margins.

Crocs (CROX) – Crocs jumped 2.4% in premarket action after the casual shoe maker’s stock was upgraded to “buy” from “hold” at Loop Capital.

Stellantis (STLA) – Stellantis shares slid 6% in the premarket after a union workers report said the worldwide chip shortage could cut the automaker’s Italy-based production by about 220,000 vehicles this year. Stellantis produced about 14% fewer vehicles during the first half of 2022 compared with the same period a year ago.

Hecla Mining (HL) – The mining company announced a deal to acquire all of the Alexco Resource shares it didn’t already own in a stock swap transaction. Hecla will also pay Wheaton Precious Metals (WPM) $135 million to terminate its joint venture with Alexco. Hecla rose 1% in premarket action.

HP Inc. (HPQ) – The computer and printer maker’s shares fell 1.9% in premarket trading after Evercore downgraded the stock to “in line” from “outperform”. The downgrade comes amid a slowdown in demand for personal computers.

AstraZeneca (AZN) – The drug maker announced a deal to buy biotech firm TeneoTwo in a deal that could be worth up to $1.17 million if certain milestones are reached. AstraZeneca fell 1.1% in the premarket.

Products You May Like

Articles You May Like

Rivian (RIVN) earnings Q3 2024
The Resident Evil 2 remake will shuffle its way to Apple devices in December
China announces $1.4 trillion package over five years to tackle local governments’ ‘hidden’ debt
Confidence Man, Shygirl and more to join Barry Can’t Swim at All Points East 2025
Meta to Offer Less Personalised Ads in Europe to Appease Regulators